4-butyrolactone has been researched along with prednisolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brain, PH; Dunn, AL; Greenwell, CM | 1 |
| Chen, TT; Cui, J; Hua, YQ; Huang, TY; Li, MY; Lin, ZW; Yang, F | 1 |
2 other study(ies) available for 4-butyrolactone and prednisolone
| Article | Year |
|---|---|
Metaphyseal osteopathy in three Australian Kelpie siblings.
Topics: 4-Butyrolactone; Animals; Australia; Bone Diseases, Developmental; Dog Diseases; Dogs; Fatal Outcome; Female; Histocytochemistry; Lameness, Animal; Male; Prednisolone; Radiography; Siblings; Sulfones | 2014 |
Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway.
Topics: 4-Butyrolactone; Angelica sinensis; Animals; Apoptosis; Bone Density Conservation Agents; Cell Line; Disease Models, Animal; Embryo, Nonmammalian; Gene Expression Regulation; Green Fluorescent Proteins; Larva; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Osteoporosis; Prednisolone; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, G-Protein-Coupled; Zebrafish; Zebrafish Proteins | 2019 |